<DOC>
	<DOC>NCT00321438</DOC>
	<brief_summary>The purpose of this study is to measure viral tropism over time in subjects with X4-tropic or non-phenotypeable virus while receiving standard of care therapy. This is an observational study. No investigational treatment will be administered through this study.</brief_summary>
	<brief_title>Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIVinfected. Screening viral load at least 5000copies/mL. X4tropic only or nonphenotypeable virus at screening. Total prior antiretroviral experience of at least 3 months and documented resistance to at least one drug in each of the following classes: NRTI, NNRTI, and PI, stable antiretroviral regimen (or no antiretroviral treatment) for at least 4 weeks before screening. Able to receive a ritonavirboosted protease inhibitor during treatment studies. Women of childbearing potential must use specific forms of contraception. Exclusion criteria: R5tropic only or R5/X4tropic virus at screening, changes to antiretroviral therapy from 4 weeks prior to screening until Day 1 of observational study. Pregnant or breastfeeding women. Significant ECG abnormalities or significant history of active pancreatitis, hepatitis, opportunistic infections, cancer, or severe illness. Current use of certain medications may exclude participation in this study. Additional qualifying criteria and laboratory test requirements to be determined by study physician.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>GW873140</keyword>
	<keyword>CCR5 antagonist</keyword>
	<keyword>experienced</keyword>
	<keyword>treatment experienced</keyword>
</DOC>